BOSTON, Mass. – October 2nd, 2026 – Averna Therapeutics, Inc., a biotechnology company developing novel genomic medicines based on gene insertion technology, announced the appointment of Christian Dombrowski, Ph.D., to Chief Technology Officer. Dr.
Need help?
Contact usBOSTON, Mass. – October 2nd, 2026 – Averna Therapeutics, Inc., a biotechnology company developing novel genomic medicines based on gene insertion technology, announced the appointment of Christian Dombrowski, Ph.D., to Chief Technology Officer. Dr.